POSA8 Indirect Comparison Analysis of United States Food and Drug Administration-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.083
https://www.valueinhealthjournal.com/article/S1098-3015(21)01878-7/fulltext
Title :
POSA8 Indirect Comparison Analysis of United States Food and Drug Administration-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01878-7&doi=10.1016/j.jval.2021.11.083
First page :
Section Title :
Open access? :
No
Section Order :
10453